Rituximab-Induced Interstitial Lung Disease: Case Report and Literature Review

Aymen Zayen,Henda Rais,Hela Rifi,Mouna Ouarda,Mehdi Afrit,Aziz Cherif,Amel Mezline

Rituximab-Induced Interstitial Lung Disease: Case Report and Literature Review

2011

Aymen Zayen
Henda Rais
Hela Rifi
Mouna Ouarda
Mehdi Afrit
Aziz Cherif
Amel Mezline

Rituximab, a chimeric monoclonal antibody against CD20, very rarely causes lung toxicity. Toxicity may present as interstitial lung disease, alveolar hemorrhage and adult respiratory distress syndrome

Keywords:

Diabetes mellitus
Diffuse alveolar damage
Rituximab
Interstitial lung disease
CD20
Lung
Respiratory distress
Immunology
Monoclonal antibody
Medicine
Toxicity
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations